Morical Gregory J 4

What Happened Gregory J. Morical, Senior Vice President and General Counsel of Calumet, Inc. (CLMT), was granted a total of 1,336 restricted stock units (RSUs) on 2026-03-31 (1,002 RSUs and 334 RSUs). Each RSU is the economic equivalent of one share of Calumet common stock and the awards were recorded at $0.00 per unit (derivative awards), so no cash was paid by the reporting person.

These are award/grant transactions (code A) rather than open-market purchases or sales; the grants reflect compensation/deferral arrangements, not a market buy or sell.

Key Details

• Transaction date and filing: Grants dated 2026-03-31; Form 4 filed 2026-04-02 (appears to be timely for a Form 4 filing).
• Amounts and price: 1,002 RSUs @ $0.00 and 334 RSUs @ $0.00 (total 1,336 RSUs; total reported cash value $0).
• Derivative treatment: Reported as derivative awards (Restricted Stock Units); F1 confirms 1 RSU = 1 share economic equivalent.
• Vesting/settlement:
  • The 1,002 RSUs (F2) are 100% vested and will settle upon the earlier of a specified date or the reporting person’s termination.
  • The 334 RSUs (F3) are under the Deferred Compensation Plan and vest 25% on July 1 of each year beginning July 1, 2027; they also settle upon the earlier of a specified date or termination.
• Shares owned after transaction: Not specified in the disclosed Form 4.
• No sale/10b5-1 plan or tax-withholding note was indicated in the filing.

Context RSU grants are a form of compensation rather than an investment purchase; vested RSUs entitle the holder to receive shares (or cash equivalent) per the plan terms at settlement. Because part of the grant is fully vested and part is subject to multi-year vesting under a deferred compensation plan, the economic exposure and timing of any actual share receipt differ between the two tranches. These awards do not by themselves indicate insider buying or selling pressure in the market.